TIAA CREF Investment Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $729K | Hold |
16,284
| – | – | ﹤0.01% | 2453 |
|
2018
Q4 | $782K | Sell |
16,284
-160
| -1% | -$7.68K | ﹤0.01% | 2378 |
|
2018
Q3 | $1.1M | Sell |
16,444
-403
| -2% | -$26.9K | ﹤0.01% | 2380 |
|
2018
Q2 | $792K | Buy |
16,847
+1,574
| +10% | +$74K | ﹤0.01% | 2589 |
|
2018
Q1 | $863K | Sell |
15,273
-1,009
| -6% | -$57K | ﹤0.01% | 2509 |
|
2017
Q4 | $807K | Sell |
16,282
-11,924
| -42% | -$591K | ﹤0.01% | 2568 |
|
2017
Q3 | $2.15M | Buy |
28,206
+13,137
| +87% | +$1,000K | ﹤0.01% | 2127 |
|
2017
Q2 | $1.42M | Sell |
15,069
-4,126
| -21% | -$388K | ﹤0.01% | 2373 |
|
2017
Q1 | $1.53M | Sell |
19,195
-1,142
| -6% | -$90.7K | ﹤0.01% | 2298 |
|
2016
Q4 | $1.69M | Sell |
20,337
-4,628
| -19% | -$385K | ﹤0.01% | 2271 |
|
2016
Q3 | $2.79K | Sell |
24,965
-382
| -2% | -$43 | ﹤0.01% | 1989 |
|
2016
Q2 | $2.81M | Buy |
25,347
+4,475
| +21% | +$496K | ﹤0.01% | 1921 |
|
2016
Q1 | $2.18M | Hold |
20,872
| – | – | ﹤0.01% | 2015 |
|
2015
Q4 | $1.68M | Sell |
20,872
-799
| -4% | -$64.4K | ﹤0.01% | 2274 |
|
2015
Q3 | $1.5M | Sell |
21,671
-1,859
| -8% | -$129K | ﹤0.01% | 2317 |
|
2015
Q2 | $2.3M | Buy |
23,530
+5,385
| +30% | +$527K | ﹤0.01% | 2212 |
|
2015
Q1 | $1.78M | Hold |
18,145
| – | – | ﹤0.01% | 2292 |
|
2014
Q4 | $2M | Sell |
18,145
-6,857
| -27% | -$755K | ﹤0.01% | 2234 |
|
2014
Q3 | $2.96M | Sell |
25,002
-33,468
| -57% | -$3.96M | ﹤0.01% | 1969 |
|
2014
Q2 | $7.59M | Buy |
58,470
+851
| +1% | +$110K | 0.01% | 1377 |
|
2014
Q1 | $9.21M | Buy |
+57,619
| New | +$9.21M | 0.01% | 1186 |
|